ReviewFrontiers in pharmacology2022

A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis.

Solveig A van der Vegt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.